Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain
Open Access
- 31 July 2004
- journal article
- research article
- Published by Elsevier BV in Nuclear Medicine and Biology
- Vol. 31 (5), 533-541
- https://doi.org/10.1016/j.nucmedbio.2004.03.001
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Switching to Reboxetine: An Efficacy and Safety Study in Patients With Major Depressive Disorder Unresponsive to FluoxetineJournal of Clinical Psychopharmacology, 2003
- Regulatory Effects of Reboxetine Treatment Alone, or Following Paroxetine Treatment, on Brain Noradrenergic and Serotonergic SystemsNeuropsychopharmacology, 2003
- Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.The Journal of Clinical Psychiatry, 2002
- Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity DisorderNeuropsychopharmacology, 2002
- Effects of the Selective Norepinephrine Reuptake Inhibitor Reboxetine on Norepinephrine and Serotonin Transmission in the Rat HippocampusNeuropsychopharmacology, 2001
- Biogenic amine transporters: regulation in fluxCurrent Opinion in Neurobiology, 2000
- Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitorBiological Psychiatry, 2000
- Pharmacological profile of antidepressants and related compounds at human monoamine transportersEuropean Journal of Pharmacology, 1997
- Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major DepressionJournal of Neuroscience, 1997
- Down‐Regulation of Norepinephrine Transporters on PC12 Cells by Transporter InhibitorsJournal of Neurochemistry, 1997